about the author

Amber Tong

amber@endpointsnews.com @AmberTongPW
Amber Tong on LinkedIn

author articles

BAR­DA boosts the fight against an­tibi­ot­ic-re­sis­tant in­fec­tions with $144M awards

5 years ago
R&D

Pfiz­er in­fus­es $200M in­to CStone, scor­ing a sec­ond PD-L1 and out­lin­ing a sprawl­ing Chi­na pact

5 years ago
Deals
China

News brief­ing: PhI­II Alzheimer's play draws an­oth­er $33M+; Ar­ran­ta un­veils $100M+ mi­cro­bio­me man­u­fac­tur­ing site

5 years ago
News Briefing

Belén Gar­i­jo ris­es to the top at Mer­ck KGaA amid ex­ec board makeover

5 years ago
People

Slammed by FDA re­jec­tion, Aque­s­tive vows to re­file by end of year

5 years ago
FDA+

Covid-19 roundup: Re­searchers urge Pfiz­er to adopt high safe­ty stan­dard, hold vac­cine EUA un­til late No­vem­ber

5 years ago
Coronavirus

Look­ing to con­quer new ter­ri­to­ries, Or­biMed joins a $60M bet on a Bio­haven spin­out in Shang­hai

5 years ago
Financing

Soft­Bank, Morn­ing­side help put US-Chi­na AI play­er on the map with $318M bet

5 years ago
Financing
China

Galec­to reaps $64M to bring lead drug across IPF fin­ish line, while mak­ing moves in NASH and be­yond

5 years ago
Financing

J&J of­fers PhI/IIa da­ta show­ing its sin­gle-dose vac­cine can stir up suf­fi­cient im­mune re­sponse

5 years ago
Coronavirus

Covid-19 roundup: Mon­cef Slaoui says 'e­nough' af­ter War­ren calls for his fir­ing; Sci­en­tists spot­light role of ...

5 years ago
Coronavirus

No­vavax teas­es Covid-19 vac­cine tri­al de­sign as it kicks off UK study — US to fol­low next month

5 years ago
Coronavirus

Covid-19 roundup: Op­er­a­tion Warp Speed's 7th vac­cine is live at­ten­u­at­ed; Small biotech touts big suc­cess where gi­ants ...

5 years ago
Coronavirus

Chair of FDA's vac­cine ad­comm — who's al­so a lead in­ves­ti­ga­tor of Mod­er­na's vac­cine — re­cus­es her­self from ...

5 years ago
People
Coronavirus

PhII Alzheimer's fail­ure deals new blow to Roche, AC Im­mune — but the tau hy­poth­e­sis is far from dead

5 years ago
R&D

Covid-19 roundup: J&J be­gins piv­otal Phase III tri­al for vac­cine; Con­tro­ver­sial hu­man chal­lenge tri­als to be­gin in ...

5 years ago
Coronavirus

Still held down by clin­i­cal hold, No­var­tis' Zol­gens­ma falls fur­ther be­hind Bio­gen and Roche as FDA asks for a new ...

5 years ago
Cell/Gene Tx
FDA+

Can a mag­net­ic cell ther­a­py re­place corneal trans­plan­ta­tion? As eight-year jour­ney leads to the clin­ic, two broth­ers ...

5 years ago
Startups
Cell/Gene Tx

News brief­ing: Tiny Vac­cinex's drug flops in PhII Hunt­ing­ton's tri­al, stock craters; Siol­ta nabs $30M Se­ries B to ...

5 years ago
News Briefing

Zai Lab hauls in $761M from Hong Kong IPO to push Ze­ju­la, more bud­ding can­di­dates in Chi­na — re­port

5 years ago
Financing
China

#ES­MO20: Bris­tol My­ers marks Op­di­vo's sec­ond ad­ju­vant win — eye­ing a stan­dard of care gap

5 years ago
R&D
Pharma

#ES­MO20: Push­ing in­to front­line, Mer­ck and Bris­tol My­ers duke it out with new slate of GI can­cer da­ta

5 years ago
R&D
Pharma

Is­raeli biotech rais­es $57M to go where cur­rent BRAF in­hibitors can't, with back­ing from No­var­tis, SR One

5 years ago
Financing

Rocked by cus­toms in­ves­ti­ga­tion, Leg­end's CFO takes over as CEO Frank Zhang placed un­der house ar­rest

5 years ago
People
China
First page Previous page 65666768697071 Next page Last page
A service from the Financial Times